CN110448684A - Compounding nutrient solution of toxin expelling dredging and preparation method thereof - Google Patents

Compounding nutrient solution of toxin expelling dredging and preparation method thereof Download PDF

Info

Publication number
CN110448684A
CN110448684A CN201910194577.3A CN201910194577A CN110448684A CN 110448684 A CN110448684 A CN 110448684A CN 201910194577 A CN201910194577 A CN 201910194577A CN 110448684 A CN110448684 A CN 110448684A
Authority
CN
China
Prior art keywords
parts
nutrient solution
toxin expelling
compounding
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910194577.3A
Other languages
Chinese (zh)
Inventor
崔海茹
崔海勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Oubang Medical Management Co Ltd
Original Assignee
Shanghai Oubang Medical Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Oubang Medical Management Co Ltd filed Critical Shanghai Oubang Medical Management Co Ltd
Priority to CN201910194577.3A priority Critical patent/CN110448684A/en
Publication of CN110448684A publication Critical patent/CN110448684A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)

Abstract

This application discloses a kind of compounding nutrient solution of toxin expelling dredging itself and preparation methods.The compounding nutrient solution of the toxin expelling dredging includes following weight parts raw material: 1-3 parts of collagen, 2-6 parts of Radix Astragali, and 2-6 parts and 100-300 parts physiological saline of Radix Angelicae Sinensis.Present application addresses lack the technical issues of can carrying out the effectively method of toxin expelling dredging.Realize that quickly exclusion toxin, the removing stasis of blood are stifled by the application.It dredges channels and collaterals, fill blood, mitigate the five internal organs burden, reach coordinating yin and yang balance.

Description

Compounding nutrient solution of toxin expelling dredging and preparation method thereof
Technical field
This application involves medical and beauty treatment fields, compounding nutrient solution and its preparation in particular to a kind of toxin expelling dredging Method.
Background technique
Lymphatic system is defense function system important in human body, and everywhere throughout whole body, whole body has 7,800 lymph nodes. Lymphatic system, one side draining lymph liquid, the intracorporal foreign matter of removing machine, bacterium etc..Another aspect lymphatic system is body defenses Outpost, be scattered in body parts lymph node like a filter device, can effectively prevent the microorganism entered through lymphatic vessel.It is more next " toxin " that more people is concerned about is the main source of harm health, and lymphatic system is responsible for the important angle of human detoxification Color.For example, inguinal lymph is the maximum toxin expelling system of entire reproductive system.
For about 10,000,000,000 lymphocytes in activity, lymphocyte is divided into T lymphocyte and B leaching in one healthy human body Bar cell.Both from marrow, but T cell is formed in thymus gland, its major function is the external invader of phagocytosis.B cell Most important function is the various antibody of production, just as the weapon inside troop, so that let us resists external invasion Object.The toxin expelling cell surface that Lymphatic Circulation makes toxin have sufficient chance powerful with human body contacts.Solvable removing toxic substances more than 99% Waste after element and metabolism can be removed by lymphatic system.If accumulation toxin is pathogenic root, toxin expelling construction It is exactly the starting point of health.The lymphatic system of human body is very huge, wherein can most react health is shoulder neck lymph, oxter leaching Bar and inguinal lymph.
Shoulder neck lymph is connected with artery, cervical vertebra, shoulder neck, clavicle, axillary lymph and head, just as the crossroad of human body, It is the main thoroughfare on qi and blood supply head.Shoulder neck lymph is serious unsmooth, will lead to the generation of the blocking of shoulder neck and " wealth and rank packet ". And then will affect circulation, the lympha toxin expelling of face blood, cause facial color to sink, dark yellow tarnish.
Aiming at the problem that the effectively method of toxin expelling dredging can be carried out in the related technology by lacking, not yet propose at present effective Solution.
Summary of the invention
The main purpose of the application is to provide a kind of compounding nutrient solution and preparation method thereof of toxin expelling dredging, to solve to lack The problem of can carrying out the effectively method of toxin expelling dredging less.
To achieve the goals above, according to the one aspect of the application, a kind of compounding nutrient solution of toxin expelling dredging is provided.
According to the compounding nutrient solution of the toxin expelling dredging of the application
Including following weight parts raw material: 1-3 parts of collagen, 2-6 parts of Radix Astragali, 2-6 parts and 100-300 parts lifes of Radix Angelicae Sinensis Manage salt water.
Further, comprising: 1-3 parts of collagen protein powder, 2-6 parts of astragalus injection, 2-6 parts of Radix Angelicae Sinensis injection, and The compounding nutrient solution of 100-300 parts of physiological saline composition.
Further, comprising: 1 part of collagen, 2 parts of Radix Astragali, the compounding of 2 parts of Radix Angelicae Sinensis and 100 parts of physiological saline composition Nutrient solution.
Further, comprising: 3 parts of collagen, 6 parts of Radix Astragali, the compounding of 6 parts of Radix Angelicae Sinensis and 300 parts of physiological saline composition Nutrient solution.
Further, the collagen is collagenocyte stoste.
Further, the compounding nutrient solution of toxin expelling dredging further include: lidocaine, reduced glutathione, vitamin C. Specifically: collagen 2-7%, Radix Angelicae Sinensis 1~2%, lidocaine 1~2%, reduced glutathione 1~2%, vitamin C 3 ~5%, appropriate physiological saline.
Further, the compounding nutrient solution of toxin expelling dredging further include: β thymosin extrasin.Specifically: collagen 2-7%, when Return 1~2%, lidocaine 1~2%, β thymosin extrasin 2~3%, appropriate physiological saline.
Further, the compounding nutrient solution of toxin expelling dredging further include: small one's share of expenses for a joint undertaking hyaluronic acid.Specifically: collagen 2- 7%, Radix Angelicae Sinensis 1~2%, lidocaine 1~2%, small one's share of expenses for a joint undertaking hyaluronic acid 2~3%, appropriate physiological saline.
To achieve the goals above, according to the another aspect of the application, toxin expelling dredging described in a kind of prepare is provided The method for compounding nutrient solution.
Included the following steps: according to the preparation of the application
A) raw material is chosen according to the proportion, and fructus lycii, Radix Angelicae Sinensis, Radix Glycyrrhizae, aloe are mixed first, deionized water is then added It is unified in wall-breaking machine to blend at a high speed, obtain basestocks；
B) basestocks are placed in blender and are opened and be slowly stirred, it is synchronous during being slowly stirred that lemon is added Acid, olive oil, collagen aqueous solution, vitamin E obtain facial mask nutrient solution after sufficiently fusing.
Further, facial mask nutrient solution is obtained after sufficiently fusing in step b) further include: lidocaine, reduced form is added Glutathione, vitamin C, β thymosin extrasin, small one's share of expenses for a joint undertaking hyaluronic acid.
The compounding nutrient solution that will be enriched in collagen, Radix Angelicae Sinensis injection and physiological saline is injected into the stifled region of the lymph stasis of blood, Wherein, collagen increases the degree of packing and elasticity of skin, tensioning the skin.Radix Angelicae Sinensis can accelerate blood and lymph with replenishing and activating blood It is stifled quickly to exclude toxin, the removing stasis of blood for circulation.It dredges channels and collaterals, fill blood, mitigate the five internal organs burden, reach coordinating yin and yang balance, moulded The effect of body beautification type.
Specific embodiment
It is right below in conjunction with the embodiment of the present application in order to make those skilled in the art more fully understand application scheme Technical solution in the embodiment of the present application is clearly and completely described, it is clear that described embodiment is only the application one Partial embodiment, instead of all the embodiments.Based on the embodiment in the application, those of ordinary skill in the art are not having Every other embodiment obtained under the premise of creative work is made, shall fall within the protection scope of the present application.
It should be noted that in the absence of conflict, the features in the embodiments and the embodiments of the present application can phase Mutually combination.The application is described in detail below in conjunction with embodiment.
Embodiment 1
The compounding nutrient solution of toxin expelling dredging, raw material be collagen 1-3 parts, 2-6 parts of Radix Astragali, 2-6 parts of Radix Angelicae Sinensis, with And 100-300 parts of physiological saline.
Embodiment 2
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 1 part of collagen, 2 parts of Radix Astragali, 2 parts of Radix Angelicae Sinensis, and 100- parts of physiological saline.
Embodiment 3
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 3 parts of collagen, 6 parts of Radix Astragali, 6 parts of Radix Angelicae Sinensis, and 300 parts of physiological saline.
Embodiment 4
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 2 parts of collagen, 4 parts of Radix Astragali, 4 parts of Radix Angelicae Sinensis, and The compounding nutrient solution of 200 parts of physiological saline composition.The collagen is collagenocyte stoste.
Embodiment 5
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 3 parts of collagen, 6 parts of Radix Astragali, 6 parts of Radix Angelicae Sinensis, and The compounding nutrient solution of 300 parts of physiological saline composition, further includes: lidocaine, reduced glutathione, vitamin C.
Embodiment 6
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 3 parts of collagen, 6 parts of Radix Astragali, 6 parts of Radix Angelicae Sinensis, and The compounding nutrient solution of 300 parts of physiological saline composition, further includes: β thymosin extrasin.
Embodiment 7
The compounding nutrient solution of toxin expelling dredging, raw material are as follows: 3 parts of collagen, 6 parts of Radix Astragali, 6 parts of Radix Angelicae Sinensis, and The compounding nutrient solution of 300 parts of physiological saline composition, further includes: small one's share of expenses for a joint undertaking hyaluronic acid.
The method for preparing the compounding nutrient solution of above-mentioned injection includes the following steps:
A) raw material is chosen according to the proportion, and fructus lycii, Radix Angelicae Sinensis, Radix Glycyrrhizae, aloe are mixed first, deionized water is then added It is unified in wall-breaking machine to blend at a high speed, obtain basestocks；
B) basestocks are placed in blender and are opened and be slowly stirred, it is synchronous during being slowly stirred that lemon is added Acid, olive oil, collagen aqueous solution, vitamin E obtain facial mask nutrient solution after sufficiently fusing.
Specifically, facial mask nutrient solution is obtained after sufficiently fusing in step b) further include: lidocaine, reduced form paddy is added The sweet peptide of Guang, vitamin C, β thymosin extrasin, small one's share of expenses for a joint undertaking hyaluronic acid.
It is stifled for dripping bar of the oxter stasis of blood by improving the stifled injection of the lymph stasis of blood, be conducive to following at least one effect:
Improve chest pain with distension sensation, promotes body metabolism, toxin expelling；
Prevent thoracopathy；
Improve secondary cream, large arm is fat, relaxes；
It is metabolized the garbage toxins of chest；
Reduce oxter degras, exhaust gas；
Strengthen immunity enhances heart blood supply function.
It is used for the toxin expelling dredging of shoulder neck by the compounding nutrient solution of toxin expelling dredging, is conducive to following at least one effect:
Improve sleep, dizziness headache, the dark yellow tarnish of blee；
Improve scapulohumeral periarthritis, shoulder neck pain, easy stiff neck, the symptom of failure of memory；
Improve brain Cycle Difference, blood supply insufficiency, the insufficient symptom of oxygen supply；
Improve the symptom of cervical lymph node enlargement, long acne；
Improve melanin easily precipitate, the symptom of easy long spot；
Prevent senile dementia and some cardio-cerebral diseases；
Improve abscess of throat；
Improve double chin, is conducive to lower jaw plastotype.
It is used for the toxin expelling dredging of shoulder neck by the compounding nutrient solution of toxin expelling dredging, is conducive to following at least one effect:
It is metabolized garbage toxins in pelvic cavity；
Improve renal function, female reproductive health；
It is fat to improve lower limb；
Improve hysteromyoma of gynecology, ovarian cyst；
Promote hormone, improves love life；
Palace of the Qing Dynasty blood, expelling of noxious substance in womb improve gynaecological imflammation；
It is ice-cold to improve trick；
Improve lower limb circulation, groin enlargement；
Improve lower limb numbness.
Table 1
The foregoing is merely preferred embodiment of the present application, are not intended to limit this application, for the skill of this field For art personnel, various changes and changes are possible in this application.Within the spirit and principles of this application, made any to repair Change, equivalent replacement, improvement etc., should be included within the scope of protection of this application.

Claims (10)

1. a kind of compounding nutrient solution of toxin expelling dredging, which is characterized in that including following weight parts raw material: 1-3 parts of collagen, yellow 2-6 parts of stilbene, 2-6 parts and 100-300 parts physiological saline of Radix Angelicae Sinensis.
2. the compounding nutrient solution of toxin expelling dredging according to claim 1 characterized by comprising collagen protein powder 1-3 Part, 2-6 parts of astragalus injection, the compounding nutrient solution of 2-6 parts and 100-300 parts physiological saline of Radix Angelicae Sinensis injection composition.
3. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that 1 part of collagen, 2 parts of Radix Astragali, The compounding nutrient solution of 2 parts and 100 parts physiological saline of Radix Angelicae Sinensis composition.
4. the compounding nutrient solution of toxin expelling dredging according to claim 1 characterized by comprising 3 parts of collagen, yellow 6 parts of stilbene, the compounding nutrient solution of 6 parts and 300 parts physiological saline of Radix Angelicae Sinensis composition.
5. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that the collagen is that collagen is thin Born of the same parents' stoste.
6. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that further include: lidocaine, reduction Type glutathione, vitamin C.
7. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that further include: β thymosin extrasin.
8. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that further include: small one's share of expenses for a joint undertaking hyalomitome Acid.
9. a kind of method for the compounding nutrient solution for preparing toxin expelling dredging described in claim 1, which is characterized in that including walking as follows It is rapid:
A) raw material is chosen according to the proportion, first mixes fructus lycii, Radix Angelicae Sinensis, Radix Glycyrrhizae, aloe, and deionized water is then added broken It is unified in wall machine to blend at a high speed, obtain basestocks；
B) basestocks are placed in blender and are opened and be slowly stirred, it is synchronous during being slowly stirred that citric acid, olive is added Olive oil, collagen aqueous solution, vitamin E obtain facial mask nutrient solution after sufficiently fusing.
10. the compounding nutrient solution of toxin expelling dredging according to claim 1, which is characterized in that sufficiently fused in step b) Facial mask nutrient solution is obtained afterwards further include: it is transparent that lidocaine, reduced glutathione, vitamin C, β thymosin extrasin, small one's share of expenses for a joint undertaking is added Matter acid.
CN201910194577.3A 2019-03-14 2019-03-14 Compounding nutrient solution of toxin expelling dredging and preparation method thereof Pending CN110448684A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910194577.3A CN110448684A (en) 2019-03-14 2019-03-14 Compounding nutrient solution of toxin expelling dredging and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910194577.3A CN110448684A (en) 2019-03-14 2019-03-14 Compounding nutrient solution of toxin expelling dredging and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110448684A true CN110448684A (en) 2019-11-15

Family

ID=68480575

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910194577.3A Pending CN110448684A (en) 2019-03-14 2019-03-14 Compounding nutrient solution of toxin expelling dredging and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110448684A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112451454A (en) * 2020-11-30 2021-03-09 北京金莎科技有限公司 Nutrient solution for comprehensively solving facial aging and preparation and use methods thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634250A (en) * 2004-10-18 2005-07-06 四川乐山三民药物科技开发有限公司 Compound injectio of Chinese angelica and astragalus root and its preparing process
CN101152568A (en) * 2006-09-25 2008-04-02 宝勒日 Polypeptide combination preparations having functions of accelerating angiogenesis, organ reactivation and wound healing
CN102579560A (en) * 2010-05-29 2012-07-18 甘肃中医学院 Preparation method of Chinese angelica and astragalus mongholicus mixture aqueous extract, as well as application in intervening in pulmonary fibrosis
CN105031726A (en) * 2015-09-02 2015-11-11 长春博泰医药生物技术有限责任公司 Medical collagen filling agent
CN105902604A (en) * 2016-05-20 2016-08-31 武汉理工大学 Compound medicament for treating T-cell acute lymphoblastic leukemia (T-ALL)
CN109223680A (en) * 2018-11-22 2019-01-18 广州诗蒂兰化妆品有限公司 A kind of skin whitening, moisturizing facial treatment mask and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634250A (en) * 2004-10-18 2005-07-06 四川乐山三民药物科技开发有限公司 Compound injectio of Chinese angelica and astragalus root and its preparing process
CN101152568A (en) * 2006-09-25 2008-04-02 宝勒日 Polypeptide combination preparations having functions of accelerating angiogenesis, organ reactivation and wound healing
CN102579560A (en) * 2010-05-29 2012-07-18 甘肃中医学院 Preparation method of Chinese angelica and astragalus mongholicus mixture aqueous extract, as well as application in intervening in pulmonary fibrosis
CN105031726A (en) * 2015-09-02 2015-11-11 长春博泰医药生物技术有限责任公司 Medical collagen filling agent
CN105902604A (en) * 2016-05-20 2016-08-31 武汉理工大学 Compound medicament for treating T-cell acute lymphoblastic leukemia (T-ALL)
CN109223680A (en) * 2018-11-22 2019-01-18 广州诗蒂兰化妆品有限公司 A kind of skin whitening, moisturizing facial treatment mask and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
冯建春等: "《用药如用兵 中药配伍应用》", 31 July 2018, 中国中医药出版社 *
国家药典委员: "《中华人民共和国药典临床用药须知 中药饮片卷》", 30 October 2017, 中国医药科技出版社 *
李冰: "血必净注射液对脓毒症大鼠肠系膜微循环动态变化的影响", 《中国全科医学》 *
雷燕等: "黄芪、当归及其组方促血管内皮细胞增殖作用的研究", 《中国中西医结合杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112451454A (en) * 2020-11-30 2021-03-09 北京金莎科技有限公司 Nutrient solution for comprehensively solving facial aging and preparation and use methods thereof

Similar Documents

Publication Publication Date Title
CN101028375B (en) Oral externally-applied Chinese medicinal composition for treating leucoderma
CN102919468A (en) Tea capable of tonifying kidney and strengthening essence and preparation method thereof
CN103349753A (en) Traditional Chinese medicine composition for treating kidney deficiency
CN110448684A (en) Compounding nutrient solution of toxin expelling dredging and preparation method thereof
CN103705641A (en) Traditional Chinese medicine composition for treating oligospermia and asthenozoospermia
CN101703666B (en) Chinese medicinal composition for treating irregular menstruation
CN103285114B (en) Chinese medicine liquor for treating scapulohumeral periarthritis and preparation method thereof
CN102225109B (en) Quick-acting fracture setting medicine powder
CN103157006B (en) Oral traditional Chinese medicine formula for treating osteoarthritis
CN102451378A (en) Uterus health capsule for treating gynopathy
CN1055406C (en) Prescription and preparation technology of sanlu (Three-Deer) kidney-warming tonic wine
CN105079382A (en) Trotter soup capable of promoting postpartum lactation
CN110170040A (en) Improve the stifled injection and preparation method thereof of the lymph stasis of blood
CN102755371A (en) Traditional Chinese medicine for adjuvantly treating amputated limb and finger replantation
CN108201139A (en) Ginseng sheep marrow peptide combinations and its application
CN103566245B (en) A kind of medicine for the treatment of nephropathy
CN103585563A (en) Traditional Chinese medicine powder for treating female infertility resulted from fallopian tube obstruction
CN102068524A (en) Medicated wine for treating rheumatoid disease and preparation method thereof
CN105878774A (en) Plaster and preparation method thereof
CN106511946A (en) Traditional Chinese medicine for treating chronic glomerulonephritis and preparation method thereof
CN1596929A (en) Plaster for treating acute and chronic muscle and bone disease and its preparation method
CN105168415A (en) Preparation for relieving pain in neck, waist and bones
CN104146399B (en) A kind of large intestine channel health caring clothing
CN105287903A (en) Treating medicine for subacute myelogenous leukemia
CN105796987A (en) Traditional Chinese medicinal composition for treating preceded menorrhea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination